| __timestamp | Dynavax Technologies Corporation | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84580000 | 22223073 |
| Thursday, January 1, 2015 | 86943000 | 6966842 |
| Friday, January 1, 2016 | 84493000 | 9000499 |
| Sunday, January 1, 2017 | 64988000 | 13741186 |
| Monday, January 1, 2018 | 74951000 | 19040000 |
| Tuesday, January 1, 2019 | 62331000 | 23559000 |
| Wednesday, January 1, 2020 | 28607000 | 31931000 |
| Friday, January 1, 2021 | 32228000 | 44981000 |
| Saturday, January 1, 2022 | 46600000 | 54234000 |
| Sunday, January 1, 2023 | 54886000 | 63806000 |
Data in motion
In the ever-evolving world of biotechnology, research and development (R&D) investments are crucial for driving innovation and growth. Over the past decade, Viking Therapeutics, Inc. and Dynavax Technologies Corporation have demonstrated contrasting strategies in their R&D expenditures.
From 2014 to 2023, Dynavax's R&D spending peaked in 2015, with a gradual decline thereafter. By 2023, their investment had decreased by approximately 37% from its 2015 high. This trend reflects a strategic shift, possibly towards commercialization and product development.
Conversely, Viking Therapeutics has shown a consistent upward trajectory in R&D spending, with a nearly 187% increase from 2014 to 2023. This aggressive investment strategy underscores their commitment to innovation and pipeline expansion.
These contrasting approaches highlight the diverse strategies within the biotech sector, where R&D investment is a key driver of future success.
Comparing Innovation Spending: United Therapeutics Corporation and Viking Therapeutics, Inc.
Genmab A/S or Dynavax Technologies Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Dr. Reddy's Laboratories Limited vs Dynavax Technologies Corporation
Comparing Innovation Spending: Exelixis, Inc. and Viking Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Dynavax Technologies Corporation
Analyzing R&D Budgets: Viking Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Protagonist Therapeutics, Inc.
Comparing Innovation Spending: Viking Therapeutics, Inc. and Celldex Therapeutics, Inc.
R&D Spending Showdown: CRISPR Therapeutics AG vs Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for Amphastar Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Dynavax Technologies Corporation or MiMedx Group, Inc.: Who Invests More in Innovation?